| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 06/11/2008 | CN101198595A Aspartyl protease inhibitors |
| 06/11/2008 | CN101195626A Method for synthesizing pyrazole [3,4-d] pyrimidine-4(5H)-ketone compounds |
| 06/11/2008 | CN101195625A Antineoplastic medicament antifolate, its salt and midbody |
| 06/11/2008 | CN101195624A Method for producing zopiclone |
| 06/11/2008 | CN101195623A Method for crystal system conversion of zopiclone |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/11/2008 | CN101195589A Synthesis of temozolomide and analogs |
| 06/11/2008 | CN100393723C Phthalocyanine compound, its producing process and hear-infrared absorption dye, and near-infrared absorption light filter using with the same dye |
| 06/11/2008 | CN100393722C Inhibitors of nucleoside metabolism |
| 06/11/2008 | CN100393721C N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto |
| 06/11/2008 | CN100393714C Gyrase inhibitors and uses thereof |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385056 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 06/10/2008 | US7385055 Preparation of hymenialdisine derivatives and use thereof |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384952 1-(3-ethoxybenzyl)-4-[4-[4-[2-(dimethylamino)ethoxy]benzoyl]piperazin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine; small conductance potassium channel (SK channel) blocking activity; gastrointestinal disorders |
| 06/10/2008 | US7384946 M3 muscarinic acetylcholine receptor antagonists |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | US7384931 Constrained compounds as CGRP-receptor antagonists |
| 06/10/2008 | US7384930 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma |
| 06/10/2008 | CA2322790C Granulatimide derivatives for use in cancer treatment |
| 06/10/2008 | CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents |
| 06/05/2008 | WO2008067481A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | WO2008067222A1 Heterocyclic modulators of tgr5 |
| 06/05/2008 | WO2008066358A1 New compounds and organic light emitting diode using the same |
| 06/05/2008 | WO2008065054A1 Tricyclic indoles and (4,5-dihydro) indoles |
| 06/05/2008 | WO2007103839A3 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 06/05/2008 | WO2007065288A3 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 06/05/2008 | US20080132700 Hydrate of n-methyl-n-(3-phenyl)acetamide and processes and methods related thereto |
| 06/05/2008 | US20080132536 treatment or prophylaxis of inflammatory or allergic diseases chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, allergic rhinitis or atopic dermatitis; 4-{[1-(aminocarbonyl)-4-piperidinyl]amino}-N-[1-(2,4-dimethylphenyl)propyl]-1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxamide |
| 06/05/2008 | US20080132516 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 06/05/2008 | US20080132515 Substituted Azaquinazolines Having an Antiviral Action |
| 06/05/2008 | US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant |
| 06/05/2008 | US20080132510 to modulate ligand binding to GABAA receptors; treatment of central nervous system (CNS) disorders; anxiety, depression, a sleep disorder, attention deficit disorder, Alzheimer's dementia or short-term memory loss |
| 06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
| 06/05/2008 | US20080132495 Pyrazole Compounds that Modulate the Activity of Cdk, Gsk and Aurora Kinases |
| 06/05/2008 | US20080132492 Use of Flumazenil in the Production of a Drug for the Treatment of Alcohol Dependency |
| 06/05/2008 | US20080132486 Ligands for Nicotinic Acetylcholine Receptors, and Methods of Making and Using Them |
| 06/05/2008 | US20080132485 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 06/05/2008 | US20080132479 Oxime Derivative and Preparations Thereof |
| 06/05/2008 | US20080132477 BACE (beta-site APP-cleaving enzyme) or Cathepsin D, close homologues of beta-secretase; treating neurodegenerative diseases such as Alzheimer's; macrocyclic amides having ring sizes of 14-17 and fused 1,3-phenylene optionally with 2,4-pyridylene groups |
| 06/05/2008 | US20080132469 Sh2 domain binding inhibitors |
| 06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
| 06/05/2008 | US20080131376 Carboranylporphyrins and uses thereof |
| 06/05/2008 | DE60129697T2 Kondensierte azepinderivate und ihre verwendung als antidiuretisches mittel Condensed azepine derivatives and their use as antidiuretic agent |
| 06/05/2008 | CA2672327A1 Aza-indolyl compounds and methods of use |
| 06/05/2008 | CA2670123A1 Substituted quinazolines |
| 06/04/2008 | EP1926826A2 Class iia histone deacetylase (hdac) substrate |
| 06/04/2008 | EP1926735A1 Tetracyclic inhibitors of janus kinases |
| 06/04/2008 | EP1926734A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 06/04/2008 | EP1926733A2 Tetracyclic indole derivatives as antiviral agents |
| 06/04/2008 | EP1926731A2 Amino-aza-adamantane derivatives and methods of use |
| 06/04/2008 | EP1926730A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 06/04/2008 | EP1926729A1 Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands |
| 06/04/2008 | EP1926724A1 Analogs of dehydrophenylahistins and their therapeutic use |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | EP1478339B1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 06/04/2008 | EP1395591B1 Corticotropin releasing factor antagonists |
| 06/04/2008 | EP1392688B1 Pyrazino[1',2':1,6]-pyrido[3,4-b] indole-1,4-dione derivatives |
| 06/04/2008 | EP1373268B1 Method for the manufacture of anagrelide |
| 06/04/2008 | CN101193893A Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group |
| 06/04/2008 | CN101193892A Macrocyclic heterocyclic aspartyl protease inhibitors |
| 06/04/2008 | CN101193868A Pyrimidine derivatives for the treatment of GABA B mediated nervous system disorders |
| 06/04/2008 | CN101193859A The preparation and use of compounds as protease inhibitors |
| 06/04/2008 | CN101193635A Multicyclic compounds and methods of their use |
| 06/04/2008 | CN101190917A 3,4-dihydro-3-methyl-4-oxomidazo[5,1-d]-1,2,3,5-tetrazine-8-formic acid benzenesulfonyl furoxan esters compound, preparation method and use thereof |
| 06/04/2008 | CN101190916A Anticancer compound, preparation method and use thereof, and composition containing the compound |
| 06/04/2008 | CN100391959C Pyrimidine-5-(1H)-ketone derivative |
| 06/04/2008 | CN100391958C Chemical compounds |
| 06/03/2008 | US7381828 Forming a salt such as a tartrate or mandelate of 6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]-dioxol-4-yl]oxy}-1-ethanol, chemical intermediates |
| 06/03/2008 | US7381729 Gastrointestinal fluid solubility; adenosine-1 receptor agonist; hypertension, congestive heart failure, renal failure |
| 06/03/2008 | US7381724 6(5-chloro-2-pyridyl-)-5-[4-methyl-1-piperazinyl]carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine for tranquilizers or hypnotics |
| 06/03/2008 | US7381585 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 06/03/2008 | CA2305760C Inhibitors of nucleoside metabolism |
| 05/29/2008 | WO2008064157A1 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 05/29/2008 | WO2008064061A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 05/29/2008 | WO2008064057A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 05/29/2008 | WO2008063671A2 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008063670A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | WO2008063669A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | WO2008063668A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008063609A2 Diimide-based semiconductor materials and methods of preparing and using the same |
| 05/29/2008 | WO2008063525A1 Compounds for inhibiting mitotic progression |
| 05/29/2008 | WO2008063114A1 Amino- imidazolones and their use as medicament for treating cognitive impairment alzheimer disease, neurodegeneration and dementia |
| 05/29/2008 | WO2008062044A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/29/2008 | WO2008061663A1 Imidazo[1,5-b]pyridazinamido ligands and their complexes |
| 05/29/2008 | WO2008061657A1 Novel aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase |
| 05/29/2008 | WO2008045268A3 Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 05/29/2008 | WO2008045266A3 Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor |
| 05/29/2008 | WO2008021369A3 Tricyclic compounds and its use as tyrosine kinase modulators |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007075465A8 Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 05/29/2008 | US20080125587 Synthesis of triazole compounds that modulate HSP90 activity |
| 05/29/2008 | US20080125585 High-purity large-scale preparation of stannsoporfin |
| 05/29/2008 | US20080125465 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125452 Indolopyridines,Benzofuranopyridines and Benzothienopyridines |
| 05/29/2008 | US20080125445 5,6-Dialkyl-7-Amino-Azolopyrimidines, Method For Their Production, Their Use For Controlling Pathogenic Fungi and Agents Containing Said Compounds |
| 05/29/2008 | US20080125439 Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |